X4 Pharmaceuticals’ Mavorixafor could become a safer treatment for CN and the 4WARD Phase 3 trial in CN will be key. Click ...

Shares of Tilray Brands ($TLRY) dropped more than 16% in after-hours trading on Wednesday after the company announced that a previously approved ...

Hudson Pacific Properties is set to implement a 1-for-7 reverse stock split of its common shares, effective Dec. 1, 2025 post ...

Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

In a bold move, US President Donald Trump announced his intention to completely stop immigration from 'developing nations,' ...

Modiv Industrial offers an attractive ~8% monthly dividend yield, supported by solid AFFO growth and a resilient ...

Gov. Mike Braun announced last summer that the Miami Correctional Facility will house ICE detainees. Left unsaid is a drug ...

The shares on their own merits are not cheap, but then the range of valuations in European pharma is wider than it has been for many years. Novartis currently trades at a FactSet-compiled 2026 ...

Reuters documented at least 470 targets of retribution under Trump’s leadership – from federal employees and prosecutors to ...

A driver in Florida was arrested, accused of attempting to strike members of an LGBTQ+ running group with his Ford Bronco on ...

Most of us don’t learn this until way too late: if you’re in your 30s, you’ve already hit your bone density peak. “Peak bone ...

The Social Security program faces crucial issues including a projected trust fund shortfall by 2033, an aging population that’s reducing the worker-to-beneficiary ratio and ongoing political gridlock.